抗癌药-话题@MedSci

#抗癌药#

351篇内容 | 5644人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1314606, encodeId=4365131460641, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=赛诺菲放弃与Merrimack合作研发抗癌药物, objectType=article, longId=36874, objectId=d24c368e4d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24c368e4d4, replyNumber=0, likeNumber=0, createdTime=2014-06-25, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24c368e4d4, moduleTitle=赛诺菲放弃与Merrimack合作研发抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24c368e4d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314605, encodeId=1f8413146059c, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著, objectType=article, longId=36207, objectId=5ff03620e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ff03620e3d, replyNumber=0, likeNumber=65, createdTime=2014-06-11, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ff03620e3d, moduleTitle=ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ff03620e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314604, encodeId=8a91131460471, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=诺华公布新获批抗癌药Zykadia积极数据, objectType=article, longId=36078, objectId=c72b360e89b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c72b360e89b, replyNumber=0, likeNumber=83, createdTime=2014-06-07, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c72b360e89b, moduleTitle=诺华公布新获批抗癌药Zykadia积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c72b360e89b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314603, encodeId=30561314603a3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, objectType=article, longId=35980, objectId=36243598020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36243598020, replyNumber=0, likeNumber=68, createdTime=2014-06-06, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36243598020, moduleTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36243598020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314602, encodeId=eb391314602f5, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=NEJM：强效抗癌药ceritinib有效之治疗肺癌, objectType=article, longId=32521, objectId=2f863252123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f863252123, replyNumber=0, likeNumber=66, createdTime=2014-03-30, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f863252123, moduleTitle=NEJM：强效抗癌药ceritinib有效之治疗肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f863252123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314601, encodeId=99b91314601ba, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=JACC：关注抗癌药物的心脏毒性, objectType=article, longId=32371, objectId=a060323e1fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a060323e1fa, replyNumber=0, likeNumber=65, createdTime=2014-03-27, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a060323e1fa, moduleTitle=JACC：关注抗癌药物的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a060323e1fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314600, encodeId=96fd13146008b, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Nat Commun：抗癌药物靶向治疗新技术, objectType=article, longId=31841, objectId=55b33184181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b33184181, replyNumber=0, likeNumber=54, createdTime=2014-03-15, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b33184181, moduleTitle=Nat Commun：抗癌药物靶向治疗新技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b33184181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314599, encodeId=8b161314599b9, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=PNAS：抗癌药物竟会诱发肿瘤, objectType=article, longId=31801, objectId=53fd318011c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53fd318011c, replyNumber=0, likeNumber=65, createdTime=2014-03-14, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53fd318011c, moduleTitle=PNAS：抗癌药物竟会诱发肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53fd318011c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314598, encodeId=cdb91314598bd, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=罗氏抗癌药MetMab III期肺癌研究受挫, objectType=article, longId=31466, objectId=bba93146612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba93146612, replyNumber=0, likeNumber=69, createdTime=2014-03-06, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba93146612, moduleTitle=罗氏抗癌药MetMab III期肺癌研究受挫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba93146612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314597, encodeId=a6ed131459e8b, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=诺华抗癌药LDE225关键性BOLT研究达主要终点, objectType=article, longId=30912, objectId=3e72309122a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e72309122a, replyNumber=0, likeNumber=68, createdTime=2014-02-22, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e72309122a, moduleTitle=诺华抗癌药LDE225关键性BOLT研究达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e72309122a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314596, encodeId=99e313145966b, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=强生抗癌药Imbruvica新适应症获FDA批准, objectType=article, longId=30690, objectId=db57306904b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db57306904b, replyNumber=0, likeNumber=67, createdTime=2014-02-18, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db57306904b, moduleTitle=强生抗癌药Imbruvica新适应症获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db57306904b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314595, encodeId=b8001314595b9, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=梯瓦抗癌药Synribo获FDA完全批准, objectType=article, longId=30645, objectId=b9e230645df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9e230645df, replyNumber=0, likeNumber=54, createdTime=2014-02-16, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9e230645df, moduleTitle=梯瓦抗癌药Synribo获FDA完全批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9e230645df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314594, encodeId=9b021314594ce, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Celgene抗癌药Pomalyst获加拿大卫生部批准, objectType=article, longId=30573, objectId=a326305e350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a326305e350, replyNumber=0, likeNumber=106, createdTime=2014-02-15, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a326305e350, moduleTitle=Celgene抗癌药Pomalyst获加拿大卫生部批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a326305e350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314593, encodeId=4c47131459327, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Science：抗癌药物能治疗免疫缺陷症吗？, objectType=article, longId=27613, objectId=1ffc2e613ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ffc2e613ae, replyNumber=0, likeNumber=59, createdTime=2013-12-07, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ffc2e613ae, moduleTitle=Science：抗癌药物能治疗免疫缺陷症吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ffc2e613ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314591, encodeId=350313145915c, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=CHMP建议批准Celgene抗癌药Abraxane用于胰腺癌治疗, objectType=article, longId=27140, objectId=25b52e14085, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25b52e14085, replyNumber=0, likeNumber=101, createdTime=2013-11-28, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25b52e14085, moduleTitle=CHMP建议批准Celgene抗癌药Abraxane用于胰腺癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25b52e14085)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314592, encodeId=6e961314592f9, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=辉瑞抗癌药Xalkori获FDA正式批准, objectType=article, longId=27141, objectId=9ff52e141bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ff52e141bc, replyNumber=0, likeNumber=65, createdTime=2013-11-28, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ff52e141bc, moduleTitle=辉瑞抗癌药Xalkori获FDA正式批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ff52e141bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314590, encodeId=cee413145909d, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=拜耳抗癌药Xofigo获欧盟批准, objectType=article, longId=26817, objectId=90a82681e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a82681e63, replyNumber=0, likeNumber=51, createdTime=2013-11-22, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a82681e63, moduleTitle=拜耳抗癌药Xofigo获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a82681e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314589, encodeId=aa16131458964, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=美国研制出能迫使癌细胞自我毁灭的抗癌药物, objectType=article, longId=26519, objectId=52e526519af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52e526519af, replyNumber=0, likeNumber=77, createdTime=2013-11-14, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52e526519af, moduleTitle=美国研制出能迫使癌细胞自我毁灭的抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52e526519af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314588, encodeId=a54213145883f, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=ACS Nano：新纳米粒子可将抗癌药送入细胞, objectType=article, longId=26311, objectId=3d742631100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d742631100, replyNumber=0, likeNumber=60, createdTime=2013-11-08, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d742631100, moduleTitle=ACS Nano：新纳米粒子可将抗癌药送入细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d742631100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314587, encodeId=6aa0131458e2c, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准, objectType=article, longId=25213, objectId=d462252130c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d462252130c, replyNumber=0, likeNumber=113, createdTime=2013-10-10, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d462252130c, moduleTitle=勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d462252130c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌药

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

赛诺菲放弃与Merrimack合作研发抗癌药物

2014-06-25

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著

2014-06-11

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

诺华公布新获批抗癌药Zykadia积极数据

2014-06-07

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

ASCO 2014：“界定”抗癌药物研发的“临床价值”

2014-06-06

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

NEJM：强效抗癌药ceritinib有效之治疗肺癌

2014-03-30

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

JACC：关注抗癌药物的心脏毒性

2014-03-27

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

Nat Commun：抗癌药物靶向治疗新技术

2014-03-15

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

PNAS：抗癌药物竟会诱发肿瘤

2014-03-14

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

罗氏抗癌药MetMab III期肺癌研究受挫

2014-03-06

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

诺华抗癌药LDE225关键性BOLT研究达主要终点

2014-02-22

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

强生抗癌药Imbruvica新适应症获FDA批准

2014-02-18

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

梯瓦抗癌药Synribo获FDA完全批准

2014-02-16

智智灵药 (审核中...)

前往app查看评论内容

#抗癌药#

Celgene抗癌药Pomalyst获加拿大卫生部批准

2014-02-15

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

Science：抗癌药物能治疗免疫缺陷症吗？

2013-12-07

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

CHMP建议批准Celgene抗癌药Abraxane用于胰腺癌治疗

2013-11-28

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

辉瑞抗癌药Xalkori获FDA正式批准

2013-11-28

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

拜耳抗癌药Xofigo获欧盟批准

2013-11-22

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

美国研制出能迫使癌细胞自我毁灭的抗癌药物

2013-11-14

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

ACS Nano：新纳米粒子可将抗癌药送入细胞

2013-11-08

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准

2013-10-10

科室
- - 订阅+
  - 更多科室
工具
服务